Invacare Corp. (IVC, Financial) is a leading provider of mobility and seating solutions (wheelchairs) and home medical equipment for non-acute care settings. The company reported solid 2Q19 results with strong cash flows giving investors confidence in the company’s ability to execute a massive turnaround. Cost pressures from tariffs and reimbursement changes in its Home Medical Equipment business have been addressed and a number of new product launches are slated for the second half of the year. Management remains committed to hitting its $85-105mm run-rate EBITDA target by 4Q20.
From Keeley Asset Management's Keeley Small-Mid Cap Value Fund third-quarter 2019 shareholder letter.
